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Rambutan peel extractABSTRACT
Objective: To monitor the physiological characteristics and genes expression of obesity
rat model after rambutan peel extract (RPE) treatment.
Methods: Twenty-four 12-week-old male rats were divided into 4 groups: normal,
obesity, obesity treated with ellagic acid (O-EA) and obesity treated with RPE30 (O-
RPE30). Physiological characteristics were monitored by measuring body weight, calorie
intake, size of adipocyte and level of triglyceride. Peroxisome proliferator activated re-
ceptor gamma (PPARg), CCAAT/enhancer-binding proteins a and fatty acid binding
protein 4 (FABP4) expression were observed using immunohistochemistry, Western
blotting and quantitative RT-PCR methods.
Results: Body weight gain of O-EA and O-RPE30 rats were lower than obesity group
and size of adipocyte cells were smaller than obesity group (P < 0.05), but when we
compared to normal group, those groups had higher body weight gain and larger
adipocyte cells. The level of triglycerides, protein expression of PPARg and mRNA level
of FABP4 genes were signiﬁcantly downregulated on O-EA and O-RPE30 compared to
obesity group (P < 0.05). Our results indicated that RPE had potential substance as in-
hibitor of body weight gain, declining of size of adipocyte, level of triglycerides, PPARg
expression and mRNA level of FABP4 gene on obesity rat model.
Conclusions: RPE have anti-obesity activity by inhibiting body weight gain, declining
size of adipocyte, decreasing triglyceride, PPARg expression and mRNA level of FABP4
gene on obesity rat model.1. Introduction
High fat and carbohydrate diet has an important role in the
stimulation of pre-adipocytes maturation and the up-regulation ofadipogenesis genes [1,2]. High carbohydrate and fat diet will
stimulate some growth factors to be released, such as platelet
derivate growth factor, vascular endothelial growth factor and
insulin like growth factor-1 (IGF-1) [3–7]. IGF-1 has an important
role in pre-adipocytes maturation both in vivo and in vitro [8,9].
Activation of IGF-1 stimulates mitogen-activated protein kinase
(MAPK) and genes cascade pathway which have role in adipo-
genesis [1,10,11]. The activation of IGF-1 will induce the activation
of extracellular regulated kinase 1-2 (ERK1-2) and MAPK mem-
bers. These proteins will initiate the expression of CCAAT/
enhancer binding protein b (C/EBPb) that is important to induce
the expression of CCAAT/enhancer binding protein a (C/EBPa)an open access article under the CC BY-NC-ND
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expression of C/EBPa and PPARg provide the expression of fatty
acid binding protein 4 (FABP4), lipoprotein lipase and 1-
acylglycerol-3-phosphate O-acyltransferase proteins that have the
same role in pre-adipocytesmaturation [13]. Obesity is the condition
when adipocyte tissue is increased by cell proliferation or cell
enlargement [14]. Obesity is related to high intake of fat and
carbohydrate that enter into body. Inhibition of adipocyte
maturation is important way to prevent obesity development.
Early process inhibits MAPK activity by speciﬁc compound to
protect adipogenesis [15,16]. Various speciﬁc compounds from
plants can reduce the activity of various lipase enzymes, reduce
MAPK activity and can be used for related disease treatment [17].
Rambutan peel extract (RPE) compound has potential as anti-
hyperglycemic and anti-acid synthase [18,19]. RPE compounds
have the ability to reduce MAPK and ERK1-2 activity. Re-
ductions of ERK1-2 activity are linked to the expression of C/
EBPa and PPARg which are the key of adipogenesis. RPE extract
reduces IGF-1 and IGF-1R expression on obesity rat model [19,20].
Regulation of adipogenesis genes is the key in obesity prevention
[21]. This research focusing on monitoring body weight, calorie
intake, size of adipocyte cells, level of triglyceride and
expression of PPARg, C/EBPa and FABP4 of visceral fat by
using immunohistochemistry (IHC), Western blotting and
quantitative RT-PCR (qRT-PCR) analyses of obesity-induced
high calorie diet rat model.
2. Materials and methods
2.1. Preparation of experimental animal
Rats were obtained from a laboratory animal provider in
Bandung, Indonesia. They were treated with normal and high
calorie diet after weaning until the 12th week. The composition
of normal food was 63% carbohydrate, 3% fat, 13% protein,
21% vitamin and mineral (manufactured by PT Comfeed,
Indonesia) and obesity model rat was treated with 74% carbo-
hydrate, 6% fat, 20% protein, vitamins, minerals and 1% ﬁber
(manufactured by PT Phokphand, Indonesia). Rats obesity level
was measured according to Lee index [22]. The rats were
maintained at Biosciences Laboratory, Brawijaya University.
2.2. RPE preparation
The RPE extract was prepared from 0.5 g dried rambutan
peel and 10 mL of distillated aquadest then homogenized
using centrifuge (10000 r/min, 5 min). Supernatant was ﬁltered
using 0.45 mm Millipore. Rats were treated using RPE 30 mg/kg
body weight (based on previous research) from 50 mg/mL stock
solution. Volume of RPE that used for oral administration was
2 mL.
2.3. Treatment
Rats were divided into 4 groups: non-treatment rats as normal
control, non-treatment obesity rats, obesity rats with ellagic acid
(O-EA) treatment as positive control and obesity rats with RPE
30 (O-RPE30) mg/kg body weight treatment. RPE was given
orally once every two days, for 12 weeks. The study was
approved by institutional ethic committee (Brawijaya University
Research Ethics Committee).2.4. RPE evaluation on calorie intake, body weight,
weight of visceral fat and level of triglycerides
Calorie intake was determined (g/rat/day). The calorie intake
was calculated [food intake multiplies total calorie diet (kcal)].
The animal body weights were recorded weekly. The body
weight gain number was calculated from ﬁnal body weight
minus initial body weight. Twelve weeks after treatment, the rats
were dissected under low concentration of ether anesthesia.
Blood was collected at centrifuge tubes, stored at room tem-
perature (RT) until serum and blood separated. And then, this
collected tube was centrifuged at 3000 r/min at RT for 15 min.
Serum samples were frozen for biochemical analysis. Visceral
fat was taken from the dorsal side and weighted. Visceral fat was
divided into two parts. First part was washed in phosphate
buffered saline (PBS) and ﬁxed in 4% of paraformaldehyde for
IHC and the second part was prepared for immunoblotting
analysis. Visceral fat was washed in PBS-diethylpyrocarbonate
for total RNA isolation preparation.
2.5. Expressions of C/EBPa, PPARg and FABP4
2.5.1. IHC
Adipocytes tissue was stained using hematoxylin-eosin. C/
EBPa, PPARg and FABP4 expressions were observed using IHC
staining [23]. Rabbit C/EBP primary antibody (no.cat. SC61),
rabbit PPARa primary antibody (no.cat. SC3456), and goat
FABP4 primary antibody (no.cat. SC18601) (Life Span,
BioScience) were dissolved in 2% bovine serum albumin
(BSA) (1:1500) and incubated for 1 h. The secondary antibody
we used was anti-rabbit immunoglobulin G (IgG) and anti-goat
IgG (Lifespan Bioscience) that were dissolved in 2% BSA
(1:2000) then incubated for 1 h. The adipocytes tissue was
visualized by hypothalamic regulatory peptides-conjugated sec-
ondary antibody substrate (Zymed). The slides were washed three
times for 10 min using PBS. The slides were dried and mounted
with Canada balsam (Sigma) and then observed using Olympus
1000 microscope. Adipocytes that expressed PPARg gene and
genes relatedC/EBPa and FABP4were indicated by nucleus with
brown color. Each slide was observed in 5 areas, each area seen
50 cells. Cells which expressed PPARg, C/EBPa and FABP4
were calculated. Average of cells which expressed PPARg, C/
EBPa and FABP4 were presented in graph.
2.5.2. Western blotting
The visceral fat tissues were pulverized using mortar and
pestle, then added 500 mL extract buffer (1 mmol/L phenyl-
methanesulfonyl ﬂuoride in dimethylsulfoxide, 50 mmol/L pH
7.4 KH2PO4, 0.5% Nonidet P.40, d-dH2O). The solution was
centrifuged at 4 C and 10000 r/min for 15 min. Protein from
visceral fat was separated using 12.5% sodium dodecyl sulfate
polyacrylamide gel and transferred to nitrocellulose membrane
(Millipore, Billerica, MA) based on a wet transfer (Bio-Rad).
Rabbit C/EBPa primary antibody, rabbit PPARg primary anti-
body, and goat FABP4 primary antibody (Lifespan Bioscience)
were dissolved in 2% BSA (1:1500) and incubated overnight at
4 C, then washed with Tris-buffered saline. The secondary
antibody, anti-rabbit IgG and anti-goat IgG (Lifespan Biosci-
ence) was dissolved in 2% BSA (1:2 000), and then was
visualized by Western Blue secondary antibody substrate (KLP).
Membrane with speciﬁc probe was observed using ChemiDoc-
Table 1
Speciﬁc primer design for one-step qRT-PCR.
Genes Sequence
PPARg PPARg-F-50-TCTGGGAGATCCTCCTGT T-30
PPARg-R-50-CAATCGGATGGTTCTTCGGA-30
C/EBPa C/EBPa-F-50-CGACTTCTACGAGGCGGAG -30
C/EBPa-R-50-TGGCTTTATCTCGGCTCTTG-30
FABP4 FABP4-F-50-GGACCTGGAAACTCGTCTCC-30
FABP4-R-50-GGACCTGGAAACTCGTCTCC-30
EF ER-F-50-ACCACCAGCTTGTCACCATC-30
ER-R-50-CCAGGAAGAGCTTCACTCAAAGCTT-30
Sri Rahayu Lestari et al./Asian Pac J Trop Biomed 2015; 5(10): 852–857854imaging (Bio-Rad) and counted the speciﬁc protein bands by
Quantity One software.
2.6. RNA isolation from visceral fat
Total RNA extraction was using NucleoSpin® RNA
Macherey-Nagel (Germany). About 30 mg visceral fat had been
pulverized using mortar and pestle. The extraction was added
500 mL RA1 buffer and 3.5 mL b-mercapto-ethanol. The pul-
verized fats were centrifuged at 13000 r/min for 1 min. Lysate
was ﬁltered using a violet ring and placed on the collecting tube
then centrifuged at 15000 r/min for 1 min. The supernatant was
transferred in a 1.5 mL tube, then added 350 mL of 70% ethanol
and homogenized. Lysate was transferred in column blue ring
and centrifuged at 15000 r/min for 30 s then was added 350 mL
membrane desalting buffer and centrifuged at 15000 r/min for
1 min. DNAase reaction mixture was added to the center of
silica membrane and incubated around 15 min at RT. The silica
membrane was washed 3 times, ﬁrst added 200 mL buffer RA2,
second added 600 mL buffer RA3 and ﬁnally added 250 mL
buffer RA3, centrifuged at 15000 r/min for 1 min and discarded
ﬂow-through. NucleoSpin® RNA II column (light and blue ring)
was placed into collection tube (1.5 mL) then added 60 mL
buffer elution (RNase-free H2O) and centrifuged for 1 min at
15000 r/min. RNA total concentration was measured using
NanoDrop spectrophotometer (ND2000).
2.7. qRT-PCR
qRT-PCR was designed using rat speciﬁc primer (Table 1).
The procedure of q-RT was based on one-step RT-PCRFigure 1. Size of adipocyte on visceral fat stained with hematoxylin eosin (sc(Sigma–Aldrich) kit. Concentration of RNA for qRT-PCR was
10 ng/mL.
2.8. Statistical analysis
One way ANOVA was used for statistical analysis of data.
Least signiﬁcant difference test was used for determining the
signiﬁcance. A probable value of P < 0.05 was considered
signiﬁcant.
3. Results
3.1. Effect of the RPE on calorie intake, body weight,
level of triglyceride and diameter of adipocyte
Obesity rat model consumed 30% calories more than control
rat. O-EA calories intake was similar to RPE30 obesity rat
model. Body weight signiﬁcantly increased in rat fed high
calorie diet compared to control group (fed normal diet).
Obesity rats with RPE treatment had reduced body weight
gains signiﬁcantly, and it was similar to EA treatment
(P < 0.05). Level of triglycerides on obesity rat model was
different compared to normal rats, O-EA and O-RPE30
(P < 0.05). Level of triglyceride was shown on obesity-RPE30
rat model. As expected, the microanatomy slides of visceral
fats shown the adipocytes in obesity rats were signiﬁcantly
larger. After RPE treatment, adipocytes appeared smaller in
obesity rats (Figure 1). Data of the RPE effect on calorie intake,
body weight, level of triglyceride, and adipocyte size were
shown in Table 2.
3.2. IHC and Western blotting
The expression proﬁle of protein density of C/EBPa, PPARg
and FABP4 was shown in Figure 2. PPARg expression on
obesity rat model was signiﬁcantly higher than both of O-EA
and O-RPE30 rat models (P < 0.05). RPE30 treatment on
obesity rat model showed the inhibition of PPARg expression
compared with obesity rat model. It had the similar expression
proﬁle to control and O-EA treatment. C/EBPa expression was
not different among all the treatments except normal. FABP4
expression on obesity rat model showed higher expression
compared with O-EA and O-RPE30.ale: 30 mm, magniﬁcation: 400×).
Table 2
Calorie intake, body weight, size of adipocyte and level of triglycerides on normal, obesity, obesity model rat treated EA and RPE30.
Parameters Calorie intake (kcal) Body weight (g) Size of adipocyte (mm) Level of triglyceride (mg/dL)
Initial Final Gain
Normal 50.02 ± 2.90a 265.35 ± 5.61 327.55 ± 3.20 62.20 ± 2.41a 33.41 ± 1.10a 78.04 ± 21.04b
Obesity 78.68 ± 6.87b 334.05 ± 8.25 440.43 ± 4.61 106.35 ± 3.64c 104.19 ± 3.09d 118.20 ± 20.42c
O-EA 71.36 ± 6.70bc 368.00 ± 4.41 449.85 ± 9.82 81.85 ± 5.23b 75.85 ± 0.34b 76.64 ± 18.72b
O-RPE30 63.69 ± 2.55c 345.87 ± 3.43 428.16 ± 1.12 82.89 ± 2.31b 90.53 ± 1.53c 42.36 ± 11.96a
The data represent the mean ± SD for six rats per group. The different abjad indicate signiﬁcance compared another (P < 0.05).
Figure 2. IHC and Western blotting of C/EBPa, PPARg and FABP4.
A1: The expressions of C/EBPa, PPARg and FABP4 on visceral fat detected by IHC (scale: 30 mm, magniﬁcation: 400×); A2: The expressions of C/EBPa,
PPARg and FABP4 protein detected by Western blotting; B1: The average cell expressions of C/EBP, PPARg and FABP4 on visceral fat; B2: The mean
density of protein C/EBPa, PPARg and FABP4. a,b: Indicate signiﬁcance (P < 0.05).
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mRNA gene C/EBPa level on obesity rat model was similar
to O-RPE30 rat model, but 12% lower than EA treatment
(Table 3). There is no difference of PPARg mRNA level in allTable 3
Level of mRNA C/EBPa gene synthesized by using primers QF1/QR1 on
visceral fat detected by qRT-PCR, normalized by EF gene. Mean ± SD %.
Samples Mean ± SD
Normal 66.4 ± 7.1
Obesity 100.7 ± 17.2
O-EA 88.4 ± 59.9
O-RPE30 10.2 ± 28.6treatment (Table 4). There was a decrease in mRNA level on
FABP4 gene, on O-EA and O-RPE30 compared to obesity.
mRNA level on O-EA treatment decreased about 40% and 30%
on O-RPE30 respectively (Table 5).Table 4
Level of mRNA PPARg gene synthesized by using primers QF1/QR1 on
visceral fat detected by qRT-PCR normalized by EF gene. Mean ± SD%.
Samples Mean ± SD
Normal 115.3 ± 3.4
Obesity 126.6 ± 72.2
O-EA 131.7 ± 66.6
O-RPE30 127.1 ± 45.5
Table 5
Level of mRNA FABP4 gene synthesized by using primers QF1/QR1 on
visceral fat detected by qRT-PCR normalized by EF gene. Mean ± SD %.
Samples Mean ± SD
Normal 50.6 ± 59.8
Obesity 100.0 ± 2.0
O-EA 60.4 ± 51.7
O-RPE30 70.0 ± 35.5
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Adipogenesis process involves various cellular activation
pathways [1,24]. MAPK pathway such as ERK1-2 activation may
lead to main adipogenesis genes expression, such as C/EBPa,
PPARg and FABP4 [25]. IHC and immunoblotting had shown
the same result which indicated high expression of PPARg in
the obesity rat model group [1].
Growth hormone is one factor that can trigger the tran-
scription of IGF-1 gene for adipocyte differentiation. It initiates
and stimulates cell on pre-adipocyte phase that has mitogenic
effect on the clonal expansion. Pre-adipocyte secretes insulin
growth factor-binding proteins which is important in modulating
the IGF-1 action on adipogenesis process [11]. IGF-1 is a ligand
that plays an important role in insulin synthesis regulation,
mitogenic factors, cell growth and differentiation through
MAPKase pathways [21,26,27].
PPARg expression was increased in obesity rat model and
was not followed by the expression of C/EBPa and FABP4. It
may be caused by C/EBPa which plays a role in PPARg acti-
vation. Two group researchers proved that C/EBPa was needed
before the adipocyte-speciﬁc gene expression [10,28]. The
activity of C/EBPa will be declined following the increase of
PPARg gene expression. C/EBPa mediates the cell at the
arrest cycle and will be declined as PPARg begins to be
expressed. Expressions of C/EBPa and FABP4 had no
difference in obesity rat model, O-EA and O-RPE30 [29]. The
expression of FABP4 is increased in obesity rat model and
decreased in O-EA, O-RPE30 and control. FABP4 plays its
role at the end of adipogenesis process and carries the
triglycerides from outside to cytoplasm of the cell. FABP4 is a
protein that carries the free fatty acid that expresses in
adipocyte [30]. The ability of RPE to act as anti-hyperglycemic
and anti-obesity agents has been reported in vitro and in vivo
[18]. The RPE and geraniin isolated from RPE possess alpha-
glycosidase, alpha amylase, and a-reductase inhibitory activ-
ities. RPE at an oral dose of 100 mg/kg could prevent inﬂam-
mation in dark agouti rats [31]. Many researches found RPE is a
safe treatment to be used in therapy [32].
O-EA treatment rat model has low expression of PPARg. EA
inhibits the adipocyte formation in 3T3-L1, PPARg and lipid
accumulation for 37% [33,34]. EA is a synthetic compound that
has been widely used as anti-obesity and anti-lipogenic that
inhibits ERK1-2. EA can block the cell cycle on G1/S phase [33].
Treatment using RPE 30 mg/kg body weight decreases PPARg
level which is similar to normal and O-EA. The declined level of
PPARg caused by the phytochemical extract of rambutan peel
activity which has the ability to bind IGF-1 and IGF-1R has a
role in ERK-1 activation pathways. Adipogenesis regulation is
activated mainly due to the bond of chemical compound with
IGF-1 receptor that declined the activity of ERK1-2 [6,35]. The
low expression of IGF-1 may be affected by the level of EAin RPE that has the same characteristic with epigallocatechin-3-
gallate, one of green tea chemical compound that is able to
inhibit IGF-1 and Ras/Raf/MAPK signaling pathways [21]. Some
active compounds that inhibit the activity of IGF-1 and its re-
ceptor are able to inhibit the MAPK signaling cascade that lead
to low expression of ERK1-2 and PPARg. RPE (30 mg/kg body
weight) decreases the expression of ERK1-2 and PPARg,
approaching the level of normal rat.
Gene expression is controlled in many steps, because it in-
volves the processes through regulation of transcription, post
transcription and translation [36]. Expressions of PPARg reduce
on O-EA and O-RPE30 rat models, but expression of C/EBPa is
not different in all of the treatments. EA is a hydrophilic
compound in rambutan peel and it may bind the surface-cell
receptor like IGF-1R and indirectly can decrease the mRNA
level of C/EBPa and PPARg [30]. This research has the same
result as research of pomegranate which can weaken adipocyte
through controlling mRNA level of MAPKs. EA of
pomegranate causes lipolysis on fat tissue and fatty acid
oxidation on liver [37].
The result of this research showed that RPE30 is more
effective than EA, due to its chemical compounds from RPEs
and synergistic work that led to a greater effect than EA treat-
ment alone [38]. RPE is an alternative way which can be used in
obesity prevention. The intensive researchers focused on
adipocyte have a chance to ﬁnd a potential medicine against
obesity and insulin resistance [6]. The main factor that caused
obesity is the increasing adipocyte, so inhibition of the
formation of fat cells is an important way to prevent obesity.
Rambutan peel is a waste material that has a potential to
regulate obesity by preventing the adipocyte formation through
normal PPARg genes on obesity rat model. Chemical com-
pounds of RPE have anti-obesity activity by inhibiting body
weight gain, declining size of adipocyte and decreasing tri-
glyceride. It also decreases the expression of PPARg and level
of mRNA FABP4 gene.
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